TickerGuard
Buy Day today: Neutral (48) Mixed market breadth · no major macro event
TENX

Tenax Therapeutics Inc

Healthcare · Biotechnology

1.90$ +2.2% vs. previous close Closing price · As of: Sep 28, 2026

Statements

Cash Flow

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Cash Flow TENX
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
– – – – – – – – – – – –
– -1.6% -87.2% -28.1% -33.8% +1,089.9% +7.0% -5.0% +4.0% -92.9% -100.0% –
– -99.2% +8.9% +7,394.3% +138.8% -99.9% +30.0% +119.4% -52.8% +52,184.4% +489.0% +1,603.4%
– -20.2% +1,920.1% -98.5% +57.3% -55.2% +33.0% +6,021.4% – – – –
– – -0.6% -302.5% – -24.1% -77.7% -695.5% – – +3.8% -243.9%
– -25.4% -97.4% +57.3% +67.4% -53.0% -2.3% +50.5% -55.7% +22.2% -100.0% –
– +0.0% – -83.1% +96.2% -100.0% – +2,150.8% -100.5% – – –
– – – – – – – – – – – –
– – – – – -98.9% +10,627.8% – – – – –
– -43.0% – – +0.0% +0.0% +0.0% -100.0% – – -19.7% -100.0%
– -99.6% +0.0% +77.7% +1,686.8% -98.9% +10,881.3% -8.1% -12.1% +58.6% +636.0% -61.4%
– -187.6% – -232.4% – -169.3% – -149.6% – – +1,009.3% -96.8%
– – – – – – – – – – – –

Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?